Neurocrine Bioscience buy Citigroup Inc.
Start price
29.10.25
/
50%
€117.75
Target price
29.10.26
€174.28
Performance (%)
15.16%
Price
18:27
€135.60
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 15.16%. This prediction currently runs until 29.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | 15.16% |
| iShares Core DAX® | -1.602% |
| iShares Nasdaq 100 | -0.781% |
| iShares Nikkei 225® | 1.289% |
| iShares S&P 500 | -0.258% |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Citigroup Inc. from $175.00 to $203.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat

